NTS VENTURES AND IHMA ANNOUNCE A COLLABORATIVE AGREEMENT TO PROVIDE AN EXTENSIVE SUITE OF CLINICAL MYCOLOGY, ANTIFUNGAL AND MICROBIOLOGY LABORATORY SERVICES TO SUPPORT ANTI-INFECTIVE DRUG DEVELOPMENT TO THE BIOPHARMACEUTICAL INDUSTRY

SCHAUMBURG, Ill., Dec 5 (Bernama-GLOBE NEWSWIRE) -- NTS Ventures (NTS), a mycology and antifungal clinical research laboratory and International Health Management Associates, Inc./IHMA Europe Sàrl (IHMA), a full-service central clinical microbiology laboratory have announced a non-exclusive collaborative agreement that will provide the pharmaceutical industry with an extensive suite of mycology and antifungal testing services and microbiology testing services, including specialties in antibacterial agents and biofilms. The suite of services includes pre-clinical in vitro and in vivo antifungal services, mechanism of action investigations, full antifungal clinical trial services and regulatory services as well as microbiology support for clinical and surveillance studies and specialty testing studies.

http://mrem.bernama.com/viewsm.php?idm=30706